Astellas Obtains Japanese Approval For Vesicare Oral Disintegration Tablets
This article was originally published in PharmAsia News
Executive Summary
Japanese regulators have approved Astellas' oral disintegration Vesicare (solifenacin) tablets to relieve symptoms of over active bladder. The launch of the OD tablets will increase treatment options for OAB patients, said the company. (Click here for more - Japanese language)